During the last session, Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s traded shares were 2.49 million, with the beta value of the company hitting 0.69. At the end of the trading day, the stock’s price was $2.70, reflecting an intraday gain of 11.11% or $0.27. The 52-week high for the PHIO share is $9.79, that puts it down -262.59 from that peak though still a striking 64.07% gain since the share price plummeted to a 52-week low of $0.97. The company’s market capitalization is $12.90M, and the average intraday trading volume over the past 10 days was 17.01 million shares, and the average trade volume was 3.98 million shares over the past three months.

Phio Pharmaceuticals Corp (NASDAQ:PHIO) trade information

Phio Pharmaceuticals Corp (PHIO) registered a 11.11% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 11.11% in intraday trading to $2.70, hitting a weekly high. The stock’s 5-day price performance is 75.32%, and it has moved by 94.24% in 30 days. Based on these gigs, the overall price performance for the year is -54.93%. The short interest in Phio Pharmaceuticals Corp (NASDAQ:PHIO) is 78709.0 shares and it means that shorts have 0.77 day(s) to cover.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 66.30%. While earnings are projected to return 147.36% in 2025.

PHIO Dividends

Phio Pharmaceuticals Corp is due to release its next quarterly earnings on 2025-Mar-30. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s Major holders

Phio Pharmaceuticals Corp insiders own 0.29% of total outstanding shares while institutional holders control 16.95%, with the float percentage being 17.00%.